More articles from Diffuse Parenchymal Lung Disease

Concomitant medications and efficacy of nintedanib in patients with IPF
Michael Kreuter, Jin Woo Song, John T. Huggins, Benoit Wallaert, Wibke Stansen, Manuel Quaresma, Bruno Crestani

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4891; DOI: 10.1183/1393003.congress-2017.PA4891
Tobacco smoking and risk for idiopathic pulmonary fibrosis: a prospective cohort study in UK Biobank
Vanesa Bellou, Lazaros Belbasis, Athanasios Konstantinidis, Evangelos Evangelou

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4887; DOI: 10.1183/1393003.congress-2017.PA4887
Discrepancy between patient expectations and experiences with anti-fibrotic drugs in idiopathic pulmonary fibrosis
Catharina Moor, Merel L. Kimman, Mirjam J.G. van Manen, Carmen D. Dirksen, Marlies S. Wijsenbeek, F. Xana Van Jaarsveld

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4884; DOI: 10.1183/1393003.congress-2017.PA4884
Role of MUC1 in idiopathic pulmonary fibrosis: mechanistic insights
Beatriz Ballester, Ines Roger, Sonia Contreras, Paula Montero, Javier Milara

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4889; DOI: 10.1183/1393003.congress-2017.PA4889
Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis
Mouhamad Nasser, Nader Chebib, Francois Philit, Agathe Senechal, Julie Traclet, Virginie Zarza, Vincent Cottin

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4876; DOI: 10.1183/1393003.congress-2017.PA4876
The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
Yoko Matsumoto, Ryutaro Furukawa, Sayaka Ohara, Kazuhiro Usui

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4885; DOI: 10.1183/1393003.congress-2017.PA4885
The programmed death of alveolar lymphocytes is elevated in idiopathic pulmonary fibrosis (IPF). The plausible explanation of well-known bronchoalveolar lavage cytological findings?
Piotr Kopinski, Tomasz Senderek, Ewelina Wędrowska, Karina Szabłowska, Grzegorz Przybylski, Joanna Chorostowska

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4888; DOI: 10.1183/1393003.congress-2017.PA4888
Tolerability and safety of anti-fibrotic agents for idiopathic pulmonary fibrosis in real world
Chikatoshi Sugimoto, Yoshikazu Inoue, Toru Arai, Takehiko Kasai, Masanori Akira, Seiji Hayashi, Kazunobu Tachibana, Yumiko Sasaki, Naoko Takeuchi, Syojiro Minomo, Naoya Ikegami

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4878; DOI: 10.1183/1393003.congress-2017.PA4878
Clinical application of the COPD assessment test (CAT) in patients with idiopathic pulmonary fibrosis
Saher Burhan Shaker, Heidi Kjeldgaard, Hanne Konradsen

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4877; DOI: 10.1183/1393003.congress-2017.PA4877
Efficacy and safety of pirfenidone in patients with IPF. A single center real-life experience
Argyris Tzouvelekis, Theodoros Karampitsakos, Evangelos Bouros, Vasilios Tzilas, Xrisoula Antonou, Nikolaos Koulouris, Demosthenes Bouros

European Respiratory Journal Sep 2017, 50 (suppl 61) PA4886; DOI: 10.1183/1393003.congress-2017.PA4886

Main menu

User menu

Search

More articles from Diffuse Parenchymal Lung Disease

Pages

Contact us